Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
11.64
-3.10 (-21.03%)
At close: May 9, 2025, 4:00 PM
11.75
+0.11 (0.95%)
After-hours: May 9, 2025, 6:54 PM EDT
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of 22, with a low estimate of 20 and a high estimate of 24. The average target predicts an increase of 89.00% from the current stock price of 11.64.
Analyst Consensus: Buy
* Price targets were last updated on Mar 13, 2025.
Analyst Ratings
The average analyst rating for Anika Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +71.82% | Mar 13, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +114.78% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +217.87% | Oct 22, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +217.87% | Aug 9, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $24 | Hold | Reiterates | $24 | +106.19% | May 29, 2024 |
Financial Forecast
Revenue This Year
114.92M
from 119.91M
Decreased by -4.16%
Revenue Next Year
124.86M
from 114.92M
Increased by 8.65%
EPS This Year
-0.60
from -3.83
EPS Next Year
-0.05
from -0.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 118.7M | 131.3M | 135.0M |
| Avg | 114.9M | 124.9M | 131.1M |
| Low | 109.8M | 117.2M | 126.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.0% | 14.2% | 8.1% |
| Avg | -4.2% | 8.6% | 5.0% |
| Low | -8.5% | 2.0% | 0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | 0.89 | -0.29 |
| Avg | -0.60 | -0.05 | -0.29 |
| Low | -1.05 | -0.60 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.